{"entity":{"id":"minsalud-colombia","kind":"institution","name":"Ministerio de Salud y Protección Social (Colombia)","aka":["MinSalud","Colombian Ministry of Health and Social Protection"],"tldr":"Colombia's health ministry. It decides each year which services and medicines the insurers must fund from the per-member payment, runs the MIPRES prescription system for the rest, and adopted a ten-year cancer control plan for 2026 to 2035.","summary":"The Ministerio de Salud y Protección Social regulates the General System of Social Security in Health. By Resolución 2765 de 2025, dated 30 December 2025, it updated for 2026 the services and technologies that insurers must fund from the capitation (UPC), with annexes listing medicines, procedures and laboratory tests; it states that, under the statutory health law, the benefit plan must be updated in full every two years. Its Resolución 1816 de 2026, dated 6 August 2026, sets how doctors prescribe through the MIPRES tool technologies not funded by the capitation, the role of each hospital's Junta de Profesionales de la Salud and the time limits for supply.\n\nBy Resolución 1233 de 2026, dated 26 June 2026, it adopted the Plan Decenal para el Control del Cáncer 2026-2035, led with the Instituto Nacional de Cancerología, with evaluations in 2028, 2030 and 2035; the first plan, for 2012 to 2021, was adopted by Resolución 1383 de 2013. In 2016 it declared imatinib a matter of public interest (Resolución 2475 de 2016) and asked the price commission, of which it is part, to set a new price, which the commission did by Circular 04 de 2016 at 206.42 pesos per milligram. The coordinates are a Bogotá centroid.","asOf":"2026-11-04","links":[{"label":"Resolución 2765 de 2025 (PDF, Spanish)","url":"https://www.minsalud.gov.co/Normatividad_Nuevo/Resoluci%C3%B3n%20No%202765%20de%202025.pdf"},{"label":"Resolución 1816 de 2026 on MIPRES (copy hosted by Consultorsalud, PDF, Spanish)","url":"https://consultorsalud.com/wp-content/uploads/2026/08/Resolucion-No-1816-de-2026.pdf"},{"label":"Resolución 1233 de 2026, Plan Decenal para el Control del Cáncer 2026-2035 (Keralty legal compilation, Spanish)","url":"https://normograma.com/keralty/compilacion/docs/resolucion_minsaludps_1233_2026.htm"},{"label":"Resolución 2475 de 2016, imatinib (PDF, Spanish)","url":"https://www.minsalud.gov.co/Normatividad_Nuevo/Resoluci%C3%B3n%202475%20de%202016.pdf"},{"label":"Ministerio de Salud y Protección Social","url":"https://www.minsalud.gov.co"}],"tags":[],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":["imatinib"],"companies":[],"institutions":["inc-colombia","invima","iets-colombia","adres-colombia","cuenta-de-alto-costo"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"city":"Bogotá","country":"CO","lat":4.711,"lng":-74.072,"institutionType":"government","website":"https://www.minsalud.gov.co","programs":["Benefits funded by the capitation (Resolución 2765 de 2025)","MIPRES prescription of non-capitation technologies (Resolución 1816 de 2026)","Plan Decenal para el Control del Cáncer 2026-2035","Comisión Nacional de Precios de Medicamentos y Dispositivos Médicos (member)","Screening rules of the health promotion pathway (Resolución 3280 de 2018)"]},"route":"/institutions/minsalud-colombia/","neighbours":{"drug":[{"id":"imatinib","kind":"drug","name":"Imatinib","route":"/drugs/imatinib/"}],"institution":[{"id":"adres-colombia","kind":"institution","name":"Administradora de los Recursos del Sistema General de Seguridad Social en Salud (ADRES)","route":"/institutions/adres-colombia/"},{"id":"cuenta-de-alto-costo","kind":"institution","name":"Cuenta de Alto Costo (Colombia)","route":"/institutions/cuenta-de-alto-costo/"},{"id":"iets-colombia","kind":"institution","name":"Instituto de Evaluación Tecnológica en Salud (IETS)","route":"/institutions/iets-colombia/"},{"id":"inc-colombia","kind":"institution","name":"Instituto Nacional de Cancerología (Colombia)","route":"/institutions/inc-colombia/"},{"id":"invima","kind":"institution","name":"Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA)","route":"/institutions/invima/"}]}}